Sensitivity and specificity for each VLE feature in predicting a histology subtype
| Histology | Wide crypts | Irregular surface | Isolated one gland | Multiple atypical glands | Complex glands | Combined atypical/complex glands |
| Normal | 10 (63%) 63%, 45% | 0 (0%) 0%, 83% | 7 (44%) 44%, 71% | 3 (19%) 19%, 52% | 0 (0%) 0%, 88% | 3 (19%) 19%, 48% |
| Carditis | 30 (56%) 56%, 43% | 4 (7%) 7.4%, 79% | 19 (35%) 35%, 73% | 24 (44%) 44%, 57% | 1 (2%) 2%, 82% | 25 (46%) 46%, 52% |
| Intestinal metaplasia | 16 (64%) 64%, 46% | 5 (20%) 20%, 87% | 7 (28%) 28%, 68% | 11 (44%) 44%, 56% | 0 (0%) 0%, 87% | 11 (44%) 44%, 52% |
| LGD | 1 (100%) 100%, 44% | 1 (100%) 100%,86% | 0 (0)% 0%, 69% | 1 (100%) 100%, 57% | 0 (0%) 0%, 89% | 1 (100%) 100%, 53% |
| HGD/IMCA | 5 (46%) 45%, 42% | 6 (55%) 55%, 90% | 1 (9%) 9%, 68% | 6 (55%) 55%, 61% | 7 (64%) 64%, 96% | 9 (82%) 81%, 57% |
| T1b | 0 (0%) 0%, 42% | 0 (0%) 0%, 85% | 0 (0%) 25%, 68% | 3 (100%) 100%, 58% | 3 (100%) 100%, 93% | 3 (100%) 100%, 54% |
| All dysplasia | 6 (40%) 40%, 41% | 7 (47%) 47%, 91% | 1 (7%) 7%, 65% | 10 (67%) 67%, 60% | 10 (67%) 67%, 99% | 13 (87%) 87%, 56% |
| Neoplasia: HGD/IMCA/T1b | 5 (36%) 36%, 40% | 6 (43%) 41%, 83% | 1 (7%) 7%, 66% | 9 (64%) 64%, 59% | 10 (71%) 71%, 99% | 12 (86%) 86%, 58% |
HGD, high-grade dysplasia; IMCA, intramucosal cancer; LGD, low-grade dysplasia.